BELIEVE Study: Nesiritide and Post Myocardial Infarction Left Ventricular Modeling

Summary

This study is being done to determine the effects (good and bad) of intravenous infusion of a human brain natriuretic peptide (BNP), Natrecor (nesiritide), a hormone produced by the heart in persons who have just suffered a heart attack. The human BNP, Natrecor (nesiritide) has been approved by the United States Food and Drug Administration (FDA) to be given intravenously for the management of acute heart failure. It is unknown if human BNP may have good effects on the pumping function of the heart after a heart attack.

Timeline

Start

2002-08

Primary completion

—

Completion

2006-01

Outcome

Outcome not reported

Stopped (Enrollment): “recruitment of subjects was halted prematurely. recruiting subjects halted prematurely”

Drugs

Indications